21.08.2023
Kaisu Sutinen joins Cerenion as Sales and Marketing Director
We are happy to welcome our first ever Sales and Marketing Director, Kaisu Sutinen! She will be based in Cerenion’s office in Helsinki, and also be a member of the management team.
Kaisu has spent her whole career in commercial and product management roles in medical device companies of various sizes and brings with her a solid understanding of business development and marketing, thus complementing the existing team.
"Cerenion has now reached a phase where our clinically validated C-Trend technology is ready to be brought to our customers in intensive care. We are therefore thrilled to have an experienced and highly talented professional like Kaisu on board to lead our sales and marketing activities", says Jukka Kortelainen, CEO of Cerenion.
"It is an honor to join a team of talented people with some really cool, emerging tech that has the potential of revolutionizing clinical practice! I have already worked with EEG based products in anesthesia and seen them change the way things are done, now it’s time to see what we can do in the acute and intensive care. This should be a thrilling ride, and I’m really looking forward to it", says Kaisu.
Highlights
This website and all of the content therein is for reference purposes only and is not intended to substitute for advice from a licensed healthcare professional. Not available in the United States. Cerenion™, Cerenion C-Trend™, C-Trend™, "The next-generation brain monitoring company"™ and "The pulse of the brain"™ are registered trademarks and/or trademarks of Cerenion Oy. Cerenion C-Trend™ is intended for use by qualified medical practitioners who will exercise professional judgment in its use. Cerenion technology is protected by Intellectual Property Rights. Patents pending worldwide. All rights reserved. © Cerenion Oy 2020.